Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/joim.12386 http://scihub22266oqcxt.onion/10.1111/joim.12386 26147380!7166513!26147380     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Intern+Med 2015 ; 278 (3): 227-37 Nephropedia Template TP {{tp|p=26147380|t=2015. Ebola virus disease: societal challenges and new treatments |pdf=|usr=}}{{26147380}} gab.com Text Ebola virus disease: societal challenges and new treatments JO: J Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=26147380 #FOAvip Ebola virus disease (EVD) is a zoonotic disease that causes severe haemorrhagic fever, with high fatality rates of up to 90% in humans. Today, there is no effective treatment available. Person-to-person transmission occurs through exposure to blood or body fluids, which can threaten other household members and first-line healthcare workers. The first cases of EVD in Guinea were identified on 22 March 2014. It was initially believed that this like previous outbreaks would be self-limiting. However, lack of public health infrastructure, delays in virus detection and late implementation of control interventions contributed to widespread transmission of EVD in a region inexperienced in dealing with the disease. Socio-cultural and economic factors probably also played a key role in the spread of the disease, resulting in the current large-scale outbreak. Some promising candidate treatments for this disease are now being developed. Twit Text FOAVip Ebola virus disease: societal challenges and new treatments ????J Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=26147380 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26147380 #FOAvip English Wikipedia <ref>{{Cite pmid|26147380}}</ref> Ebola virus disease: societal challenges and new treatments #MMPMID26147380 Mirazimi A J Intern Med 2015[Sep]; 278 (3): 227-37 PMID26147380show ga Ebola virus disease (EVD) is a zoonotic disease that causes severe haemorrhagic fever, with high fatality rates of up to 90% in humans. Today, there is no effective treatment available. Person-to-person transmission occurs through exposure to blood or body fluids, which can threaten other household members and first-line healthcare workers. The first cases of EVD in Guinea were identified on 22 March 2014. It was initially believed that this like previous outbreaks would be self-limiting. However, lack of public health infrastructure, delays in virus detection and late implementation of control interventions contributed to widespread transmission of EVD in a region inexperienced in dealing with the disease. Socio-cultural and economic factors probably also played a key role in the spread of the disease, resulting in the current large-scale outbreak. Some promising candidate treatments for this disease are now being developed. |Animals[MESH] |Antiviral Agents/therapeutic use[MESH] |Blood Transfusion[MESH] |Disease Outbreaks[MESH] |Filoviridae[MESH] |Hemorrhagic Fever, Ebola/prevention & control/therapy/*transmission[MESH] |Humans[MESH] |Socioeconomic Factors[MESH]Ebola virus disease: societal challenges and new treatments (epmc).pdf DeepDyve Pubget Overpricing